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Abstract
Background: The apicomplexan parasite Toxoplasma gondii can infect and replicate in virtually any nucleated cell in many
species of warm-blooded animals; thus, it has evolved the ability to exploit well-conserved biological processes common to
its diverse hosts. Here we have investigated whether Toxoplasma modulates the levels of host microRNAs (miRNAs) during
infection.
Methodology/Principal Findings: Using microarray profiling and a combination of conventional molecular approaches we
report that Toxoplasma specifically modulates the expression of important host microRNAs during infection. We show that
both the primary transcripts for miR-17,92 and miR-106b,25 and the pivotal miRNAs that are derived from miR-17,92
display increased abundance in Toxoplasma-infected primary human cells; a Toxoplasma-dependent up-regulation of the
miR-17,92 promoter is at least partly responsible for this increase. The abundance of mature miR-17 family members, which
are derived from these two miRNA clusters, remains unchanged in host cells infected with the closely related apicomplexan
Neospora caninum; thus, the Toxoplasma-induced increase in their abundance is a highly directed process rather than a
general host response to infection.
Conclusions/Significance: Altered levels of miR-17,92 and miR-106b,25 are known to play crucial roles in mammalian cell
regulation and have been implicated in numerous hyperproliferative diseases although the mechanisms driving their
altered expression are unknown. Hence, in addition to the implications of these findings on the host-pathogen interaction,
Toxoplasma may represent a powerful probe for understanding the normal mechanisms that regulate the levels of key host
miRNAs.
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Introduction
The intracellular protozoan parasite Toxoplasma gondii is a
ubiquitous pathogen of warm-blooded animals with approximately
one to two billion humans infected [1]. While infections in
immunocompetent adults are typically subclinical, infection
persists for the life of the host, and serious disease can occur in
fetal infections and in primary or recrudescent infection of
immunocompromised persons. During host cell invasion, Toxo-
plasma uses a specialized set of secretory organelles to inject
parasite-derived effector molecules into its host cell [2]. Some of
these effectors are known to interfere with host cell signaling
pathways and alter host defenses although the means by which
they do this are not known [3–5]. Toxoplasma appears to block
apoptotic responsiveness in its host cells at myriad points [6] and
to co-opt host apoptotic signaling pathways as an environment-
sensing mechanism [7]. Toxoplasma-infected cell cultures can also
cede control of their cell cycle, progressing through G1/S and
halting at G2/M and Toxoplasma attaches to, and invades host cells
in S phase up to 4 times more efficiently than host cells in G1 [8–
11]. In addition to these alterations in host cell signaling and cell
cycle control, Toxoplasma specifically modulates host cell gene
expression. Changes to the Toxoplasma-infected host transcriptome
have been interrogated by expression-profiling and the data
demonstrate that 24 hours post-infection, upwards of 15% of host
mRNAs display altered abundance relative to uninfected cells
[12]; similarly, quantitative analysis of the host proteome during
Toxoplasma infection showed that the abundance of many host
proteins is modulated in expression by Toxoplasma [13].
We have developed the hypothesis that some of these changes in
host gene expression involve Toxoplasma co-opting host micro-
RNAs (miRNAs), which are central components of an ancient
post-transcriptional gene-regulatory mechanism that is highly
conserved among the mammalian and avian hosts of Toxoplasma.
MiRNAs are one of the most abundant classes of gene-regulatory
molecules in the cell [14] and in silico target prediction suggests that
miRNAs may be involved in the regulation of up to 30% of the
human transcriptome [15]. Mature miRNAs are ,23 nucleotide
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double-stranded RNA molecules that base-pair with target
mRNAs. Most reports show that miRNAs act to negatively
influence the translation and/or stability of target mRNAs [16],
although under conditions of cell cycle arrest, some miRNAs
appear to increase the translation of their target mRNAs [17].
Some closely related miRNAs are grouped into families by virtue
of containing identical seed sequences (the first 6-8 nucleotides of
their mature 59 ends); miRNA seeds are instrumental in target
mRNA discrimination [18] and so individual miRNAs grouped
into the same family are believed to be functionally equivalent
[19,20].
Although miRNAs were first identified due to their regulatory
roles in sculpting metazoan development [21,22], miRNA
dysregulation also plays a central role in cancer and infection
[20,23-28]. The dysregulation of several miRNAs have been
experimentally demonstrated to promote oncogenesis [20,28].
Examples relevant to the present work are four families of
miRNAs (miR-17, miR-18, miR-19 and miR-25) that are encoded
by three paralogous loci; these related loci, which are miR-17,92,
miR-106b,25 and miR-106a,363 (see Figure 1B), produce
primary transcripts that are post-transcriptionally processed to
yield mature miR-17, miR-18, miR-19 and miR-25 family
members. MiR-17,92 is also known by the synonym OncomiR-1
due to the observed acceleration of lymphomagenesis when these
miRNAs are over-expressed in Em-Myc mice [29].
Functionally, slight perturbations to the levels of mature miR-
17,92-derived miRNAs can have profound biological conse-
quences; knock-in mice engineered to produce twice as much miR-
17,92-derived miRNAs as wildtype mice suffer lymphoprolifer-
ative phenotypes, autoimmunity and a shortened life-span linked
to the loss of the PTEN tumor suppressor and the pro-apoptotic
factor Bim, which are both validated targets of miR-17,92 [30].
Indeed, the miR-17,92 and miR-106b,25 clusters appear to
attenuate apoptotic responsiveness by targeting several mRNAs
encoding pro-apoptotic effectors and favor progression from G1 to
S-phase by targeting mRNAs that encode negative regulators of
the cell cycle [19,20].
To investigate whether Toxoplasma infection drives changes to
host miRNA levels, we profiled host miRNA levels during
Toxoplasma infection with miRNA microarrays and confirmed
these results by independent means. The data reveal numerous,
Toxoplasma-specific changes to host miRNA levels and some of
these changes are at least partly mediated at the transcriptional
level.
Results
Toxoplasma gondii Alters MiRNA Levels in Host Cells
To investigate whether Toxoplasma infection alters the steady-
state levels of host miRNAs, we profiled the levels of miRNAs
extracted from primary human foreskin fibroblasts (HFFs) during
a 24-hour Toxoplasma infection timecourse (where host RNA was
extracted at 6-hours, 12-hours and 24-hours from mock- and from
Toxoplasma-infected cells) using miRNA microarrays spotted with
duplicate probes that should hybridize to all human, mouse and
rat miRNAs included in miRbase v.8. When we compared
hybridization intensities between arrays that were hybridized with
RNA derived from uninfected HFFs and Toxoplasma-infected
HFFs, the results demonstrated that at 24-hours post-infection,
,14% of the spots displayed dissimilar hybridization intensities
(Figure S1). We focused our attention on 18 microarray spots (9
closely related human and mouse probe sequences that were
spotted in duplicate) that displayed comparable increases in
hybridization intensities on arrays hybridized with RNA derived
from infected HFFs (Figure S1, red boxes); these 18 spots
contained probes that hybridized to members of the miR-17
family (the miR-17 family is composed of miR-17, miR-106a,
Figure 1. MiRNA microarray profiling reveals that Toxoplasma
infection increases the levels of miR-17-, miR-18- and miR-19-
family members. (A) Sequence alignment of miR-17 family members.
The 6-nucleotide seed region that defines the miR-17 family is indicated
in yellow. Nucleotide differences from the miR-17 sequence are shown
in boldface blue type. (B) Genomic organization of the miR-17,92, miR-
106b,25 and miR-106a,363 clusters. Colors of each miRNA indicate
the miRNA family to which each belongs; miR-17 = yellow; miR-
18 = green; miR-19 = blue; miR-25 = red. miR-17,92 and miR-106b,25
are encoded in the 3rd intron of C13ORF25 and the 13th intron of
MCM7, respectively; for these genes, exons are indicated as boxes, and
introns are lines. (C) Microarray profiling of host miRNAs during
Toxoplasma infection. From left to right, columns are from individual
microarrays hybridized with RNA extracted from uninfected HFFs at 6,
12 or 24 hours and with RNA samples derived from HFFs infected with
Toxoplasma at 6, 12 or 24 hours. The data were normalized with the
default settings in the Stanford Microarray Database software package.
The scale of the heat-map is presented as fold-change from the median
value. The rows are the averaged data from all probes that are
predicted to hybridize to members of the indicated miRNA families;
these families represent all miRNAs encoded by the miR-17,92, miR-
106a,363 and miR-106b,25 clusters. Shown for comparison is miR-21
which is a highly expressed miRNA in HFFs and is derived from an
independent intergenic locus.
doi:10.1371/journal.pone.0008742.g001
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miR-106b, miR-20a, miR-20b and miR-93; see Figure 1A for a
sequence alignment of the miR-17 family). As miR-17 family
members are co-transcribed with members of the miR-18 (Figure
S1, blue box), miR-19 and miR-25 families, and are encoded in
three separate paralogous loci (miR-17,92, miR-106a,363 and
miR-106b,25; Figure 1B), we assembled a heat-map from our
microarray data that contains the averaged fold-change values for
all probes that hybridized to members of the miR-17, miR-18,
miR-19 or miR-25 families (18, 4, 4, and 4 probes, respectively;
Figure 1C). When evaluating these data it is important to note that
within these individual miRNA families, mature miRNAs have
nearly identical nucleotide sequences, and are virtually indistin-
guishable from the other members of their own miRNA family by
microarray, northern blotting, and conventional primer-extension
analyses.
The microarray profiling data showed that the miR-17 family
and the miRNA families that are co-transcribed with it were
generally more abundant in RNA samples from Toxoplasma-
infected cells and that the abundance of these miRNAs marginally
increased at 6-hours post-infection and showed greater increases at
12-hours and 24-hours post-infection (Figure 1C). MiR-21 is a
highly abundant unrelated miRNA in HFFs that is derived from
an independent intergenic locus and is included in the microarray
heat-map and subsequent analyses for comparison.
To validate the microarray data and to specifically measure the
effects of Toxoplasma infection on miRNAs encoded by miR-17,92,
miR-106a,363 and miR-106b,25, we took two orthogonal
approaches. First, we performed high-resolution northern blot
analysis for miR-17. Consistent with the microarray data, the
northern blot results showed that, collectively, the level of mature
miR-17 family members increased ,2.7-fold in Toxoplasma-
infected HFFs relative to uninfected HFFs (Figure S2). The data
also showed that the pre-miR-17 signal was a small fraction of the
hybridization signal observed for mature miR-17, suggesting that
the contribution of pre-miR-17 to the observed miRNA micro-
array hybridization intensity was negligible, an interpretation that
is consistent with previous data [31].
The second approach used to follow up on the microarray
results was primer-extension analysis with primers specific for each
miR family. The raw data shown in Figure 2A confirmed that the
levels of mature miR-17 family members increased as a function of
time in RNA samples derived from Toxoplasma-infected HFFs.
Primer-extensions performed with probes specific for 5S rRNA
and miR-21 gave very similar patterns to each other with no
significant effect of Toxoplasma infection (Figure 2A). MiR-18, miR-
19 and miR-25 family members also showed an increase in
abundance in RNA samples derived form Toxoplasma-infected
HFFs (Figures 2C). A graphical representation of all replicate
primer-extensions normalized to 5S rRNA is plotted in Figure 2B.
Upon Toxoplasma infection, miR-17 family members collectively
increased ,3-fold, and miR-19 and miR-25 family members
increased ,1.5-fold. When normalized to 5S rRNA, miR-18 also
increased upon Toxoplasma infection, but the measurements for the
miR-18 primer-extensions were complicated by low signal and
high background (see Figure 2A), making its measurement less
reliable; it was therefore not included in Figure 2B. Similar
primer-extension analyses were performed with probes for the
miR-17 family and 5S rRNA on RNA samples derived from two
Toxoplasma-infected mouse embryonic fibroblast lines (C57/B6/
129 [32] and NIH 3T3 [33]) and from a human B-cell line (Raji
[34]); the results of these experiments were consistent with the
primary HFF results detailed above (data not shown).
The data from the miRNA microarray profiling and primer-
extension analysis were generally in agreement except in one
instance. The microarray data (Figure 1B) indicated that the miR-
25 family of miRNAs did not appreciably increase in arrays
hybridized with RNA derived from Toxoplasma-infected cells at the
24 hour timepoint whereas primer-extension for miR-92 (the miR-
25 paralog derived from the miR-17,92 locus) indicated a modest
but reproducible increase (Figure 2B). The Cy5 channel intensities
of the miR-25 family probe spots were near the upper limits of the
dynamic range of the microarrays, which likely obscured the signal
Figure 2. Primer-extension analysis shows that Toxoplasma
infection specifically increases levels of host miR-17, miR-18,
miR-19 and miR-25 family members. (A) Total RNA samples were
extracted from HFFs during a 24-hour timecourse of Toxoplasma-
infection, and subject to primer extension analysis. From left to right,
template RNAs were derived from uninfected HFFs at 6, 12 or 24 hours,
or from infected HFFs at the same time points. Shown are
representative autoradiographs for each primer-extension probe; all
reactions were performed on biological triplicates. All probes were also
extended in the absence of template RNA (‘- RNA’ lanes) to identify any
primer-extension artifacts associated with each probe. Primer-extension
products are shown with arrows and labeled. ({) miR-20 is a member of
the miR-17 family; ({) miR-92 is a member of the miR-25 family. Excess
free probe is indicated. The size marker is a 10bp ladder. (B) A graphical
summary of the primer-extension data in (A). Each RNA sample was
subject to primer-extension with the indicated miR-specific probe and
band-intensities were quantified by phosphorimager analysis. These
values were normalized to values obtained from an independent
primer-extension of each RNA sample with a 5S rRNA probe. The 5S
rRNA-normalized infected/uninfected ratios for each timepoint are
plotted and error bars are the standard deviation between three
biological replicates that were performed for each timepoint.
doi:10.1371/journal.pone.0008742.g002
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increase seen in the primer-extensions. Excluding this discrepancy,
the primer-extension data closely approximate the results of the
northern blot and miRNA microarray profiling and confirm that
Toxoplasma increases the levels of mature miR-17, miR-18, miR-19
and miR-25 family members in infected human cells.
Increases in MiR-17 Family Members Are a Specific
Response to Toxoplasma Infection
To investigate whether the observed increase in host miR-17
levels is a specific response to Toxoplasma infection or a general
response of apicomplexan-infected host cells, we assayed the levels
of host miR-17 in HFFs infected with Neospora caninum. Neospora
and Toxoplasma are very closely related coccidians, have similar
asexual growth cycles, and are morphologically almost indistin-
guishable [35]. Although Neospora is not a human pathogen and
has a far more restricted host range than Toxoplasma, Neospora
readily infects HFFs and grows with kinetics comparable to
Toxoplasma in these cells [36]. To assess whether Neospora infection
changes the levels of host miR-17 family in a manner similar to
Toxoplasma infection, we performed primer-extension analysis on
RNA samples derived from HFFs comparably infected with
Neospora. The results showed that Neospora infection did not
significantly alter the levels of host miR-17 family members using
either a miR-17 probe (Figure 3A and Figure 3B), or miR-20
probe (data not shown) at any time-point in our assay. We
conclude that the increased level of miR-17 family members seen
in Toxoplasma-infected cells is Toxoplasma-specific and is not a
general host response to apicomplexan infection.
Toxoplasma- and Neospora-Infected HFFs Show Elevated
Levels of Pri-MiRNAs Encoding MiR-17 Family Members
To investigate whether Toxoplasma manipulates the levels of pri-
miRNAs encoding miR-17, miR-18, miR-19 and miR-25 family
members, and to query which of the paralogous clusters encoding
miR-17 family members are manipulated by Toxoplasma, we
performed northern blot analysis on pri-miR-17,92, pri-miR-
106a,363 and pri-miR-106b,25 (Figure 4). This was done using
probes that hybridize to sequences that are unique to each cluster
(sequences that encode the pre-miRNA hairpins are not recognized
by the probes; sequences provided in Figure S3), thereby allowing us
to discriminate between the three paralogous clusters. The
hybridization products with different probes were quantified by
phosphorimager analysis, normalized to the signal for the constitu-
tively expressed RPS29 to correct for loading variation, and
expressed as a fraction of the signal derived from uninfected HFFs
for each probe. A parallel analysis was performed using a probe for
AldoA as a loading control and yielded comparable numbers to those
obtained by normalization with RPS29 (data not shown).
Figure 4 shows that hybridization with the pri-miR-17,92
probe yields a ,3.2kb band which is a size previously published
for the pri-miRNA derived from this cluster [37]. The level of pri-
miR-17,92 in HFFs infected with Toxoplasma relative to uninfected
HFFs was ,3.6-fold greater whereas HFFs infected with Neospora
Figure 3. Neospora infection does not alter the levels of miR-17
family members. (A) Total RNA samples were extracted from HFFs
during a 24-hour timecourse of Neospora-infection, and subject to
primer extension analysis. From left to right, template RNAs were
derived from uninfected HFFs at 6, 12 or 24 hours, or from infected
HFFs at the same time points. Shown are representative autoradio-
graphs for primer-extension with the miR-17 and 5S probes; reactions
were performed on biological triplicates. miR-17 and 5S probes were
also extended in the absence of template RNA (‘- RNA’ lanes) to identify
any primer-extension artifacts associated with each probe. Primer-
extension products are shown with arrows and labeled. Excess free
probe is indicated. The size marker is a 10bp ladder. (B) A graphical
summary of the primer-extension data in (A); the scale has been
preserved for comparison with Figure 2B. RNA samples were subject to
primer-extension with the miR-17 probe and band-intensities were
quantified by phosphorimager analysis. These values were normalized
to values obtained from an independent primer-extension of each RNA
sample with a 5S rRNA probe. The 5S rRNA-normalized infected/
uninfected ratios for each timepoint are plotted and error bars are the
standard deviation between three biological replicates that were
performed for each timepoint.
doi:10.1371/journal.pone.0008742.g003
Figure 4. Toxoplasma-infected HFFs have elevated levels of
pri-miR-17,92 and pri-miR-106b,25. Total RNA was isolated from
uninfected HFFs (‘HFF’ lane), or HFFs infected for 24 hours with
Toxoplasma (‘HFF+Toxo’ lane) or Neospora (‘HFF+Neo’ lane). From top to
bottom panels, probes are: miR-17,92, miR-106b,25 and RPS29. The
labeling, hybridization, washes, and exposures were performed
identically for each probe. Sizes (kb) are derived from a co-resolved
RNA ladder.
doi:10.1371/journal.pone.0008742.g004
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showed no such increase (,0.7-fold relative to uninfected HFFs).
When the membrane was stripped and hybridized with a pri-miR-
106b,25 probe, infection with either Toxoplasma or Neospora
showed a major band at ,850nt, and this band demonstrated an
increase of ,2.5-fold and ,2.6-fold, respectively, relative to
uninfected HFFs (Figure 4). There are no previous reports of pri-
miR-106b,25 northern blots and so, while we cannot be certain
that this band corresponds to pri-miR-106b,25 or to a splice
variant of MCM7, it was consistently seen in multiple experiments
and is within the size range expected for this molecule. No
reproducible pri-miR-106a,363 hybridization products were
visible (data not shown).
These results suggest that the mature miR-18 and miR-19
family members that increase upon infection with Toxoplasma are
derived from miR-17,92; although pri-miR-106b,25 is also
increased in Toxoplasma-infected cells, miR-106b,25 does not
encode miR-18 and miR-19 family members and, consistent with
previous reports [32,37], no pri-miR-106a,363 was detectable.
Toxoplasma Infection Increases Transcription from the
Pri-MiR-17,92 Promoter
To investigate whether the Toxoplasma infection-dependent
increase in pri-miR-17,92 abundance is the result of increased
transcription from this locus, we performed a dual luciferase assay
with a reporter plasmid [38] containing a 1.3kb fragment located
upstream of C13ORF25 fused to a promoter-less firefly luciferase
(FLUC) cassette (pro1353::FLUC; see Figure 5A); this 1.3kb
upstream fragment of C13ORF25 overlaps the 59 terminus of the
C13ORF25 expressed sequence tag (EST) by 10 nucleotides and
has been previously shown to drive firefly luciferase expression
[38]. The pro1353::FLUC plasmid was co-transfected into HFFs
with a plasmid that constitutively expresses Renilla luciferase
(RLUC; pRL4.75). The transfected cells were either mock- or
Toxoplasma-infected and the ratio of FLUC/RLUC was deter-
mined at 18 hours post-infection.
The data demonstrate that Toxoplasma-infected HFFs show a
4.3-fold increase in FLUC/RLUC relative to mock-infected HFFs
(p = 8.861025; Figure 5B). These data strongly suggest that the
increased level of pri-miR-17,92 seen in Toxoplasma-infected HFFs
is a result of increased miR-17,92 transcription rather than
alterations in the stability of pri-miR-17,92, as only 10 nucleotides
from the pri-miR-17,92 transcript are present in the luciferase
reporter construction.
Discussion
The results presented here demonstrate that Toxoplasma
infection specifically drives an increase of 2–3 fold in the levels
of mature miR-17,92-derived miRNAs in primary human
foreskin fibroblasts. The mature miRNAs encoded by miR-
17,92 and its paralog miR-106b,25 play important roles in
mammalian biology. MiR-17,92 is crucial in development, as
mice harboring a homozygous deletion of miR-17,92 die shortly
after birth due to pulmonary and cardiac defects and develop
abnormal B-cell lymphocytes [32]. In adult animals, miR-17,92
and miR-106b,25 have been shown to influence the functionally
intertwined pathways of apoptosis and G1/S cell cycle progression
by targeting multiple components of each pathway [20]. The
importance of these functions have been demonstrated by showing
that retroviral overexpression of a cassette containing miR-17,
miR-18 and miR-19 in mice results in c-Myc-induced lymphoma
[29]. More subtly, transgenic mice that have been engineered to
overexpress miR-17,92 by 2-fold in lymphocytes develop
lymphoproliferative disease and autoimmunity and die prema-
turely, phenotypes that were shown to be partially a consequence
of the translational repression of PTEN and Bim [30]. Hence,
even relatively modest increases in the levels of miR-17,92, of a
magnitude less even than seen here with Toxoplasma infection, have
profound biological consequences in vivo.
The ultimate, downstream target of these changes in miRNAs,
in terms of benefit to the parasite, is not clear; in the set of HFF
mRNAs that decrease in abundance upon Toxoplasma infection [5],
there is no significant enrichment for mRNAs containing predicted
miR-17,92 or miR-106b,25 binding sites (data not shown). This
lack of apparent enrichment could be due to the very large
number of changes induced by Toxoplasma through other means;
for example, many transcription factors are up-regulated in
Toxoplasma-infected cells, which significantly increases the back-
ground for this kind of bioinformatics analysis. It could also signify
that the critical, intended effect of modulating these miRNAs is on
translation rather than transcription [37,39].
Figure 5. Toxoplasma infection increases pri-miR-17,92
transcription. (A) Diagram of the location of the pro1353 fragment
and its position relative to the transcribed portion of C13ORF25.
Transcription start sites of C13ORF25 and pro1353::FLUC are shown by
bent arrows. The pro1353 fragment overlaps the 59-end of the
C13ORF25 EST by 10 nucleotides [38]. (B) pro1353::FLUC/CMV::RLUC
ratios for uninfected HFFs or Toxoplasma-infected HFFs (HFF+Toxo) are
plotted. Shown are five biological replicates for each condition from a
representative experiment.
doi:10.1371/journal.pone.0008742.g005
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To understand the role of increased miR-106b,25 and/or miR-
17,92 in Toxoplasma infection we took several approaches. First,
we infected primary mouse fibroblasts (MEFs) harboring a miR-
17,92 deletion [32]. The results showed no reproducible
difference in Toxoplasma growth in such cells relative to wild type
controls (data not shown). Second, concurrent analyses using
locked nucleic acid-mediated knockdown of miR-17,92- and miR-
106b,25-derived miRNAs was performed using a wide range of
conditions in mouse fibroblasts and HFFs. The results showed no
reproducible effects of knockdown of these miRNAs on the ability
of Toxoplasma to infect, grow within and lyse the host cell in vitro
(data not shown). This absence of an effect is consistent with the
fact that while many of these miRNAs are extremely important in
the animal [30,32], they are largely dispensable for simple, in vitro
growth of cell lines (miR-17,92 knockout MEFs have no obvious
in vitro growth defect and, in general, most commonly used
transformed cell lines dramatically overexpress miR-17,92).
Extensive Affymetrix microarray profiling of Toxoplasma-infected
wildtype- or miR-17,92-knockout MEFs showed no statistically
significant differences in mouse mRNA levels 24h post infection
(data not shown).
To address what the important biological target(s) of these
miRNAs are in the context of Toxoplasma infection, in vivo studies
will be needed. Unfortunately, as homozygous miR-17,92
knockout mice are not viable [32] dissecting the impact of these
genes on Toxoplasma pathogenesis is technically difficult. The
situation is further complicated by the fact that both pri-miR-
17,92 and pri-miR-106b,25 are increased upon Toxoplasma
infection and these two clusters are believed to be partially
functionally redundant. Ultimately, a conditional knockout of miR-
17,92 in a miR-106b,25-null background will be necessary to
score the full biological role(s) of these miRNAs in Toxoplasma-
infected animals.
Whatever the biological role of these miRNAs in Toxoplasma
infection, the results presented here demonstrate that increases in
miR-17,92-derived miRNAs are a specific response to Toxoplasma
infection. During such infection only a subset of miRNAs are
affected and an increase in miR-17,92-derived miRNAs is not
seen when cells are similarly infected with the closely related
coccidian Neospora. To our knowledge this represents the first
report of a pathogen that specifically increases the levels of miR-
17,92 and/or miR-106b,25. Thus, in addition to the importance
of understanding the host-pathogen interaction, Toxoplasma and
Neospora could prove extremely useful as probes for dissecting the
biogenesis and function of miRNAs in normal, uninfected human
cells.
The levels of miR-17,92-derived miRNAs reported here are at
least partially due to a Toxoplasma-dependent increase in pri-miR-
17,92 transcription. The transcription of pri-miR-17,92 has been
shown to be positively regulated by E2F3 [38] and c-Myc [37]
transcription factors, and pri-miR-106b,25 is positively regulated
by E2F1 [40]. Expression-profiling of Toxoplasma-infected HFFs
[5] demonstrated that there are modest increases in the levels of
E2F3 (+1.4-fold), c-Myc (+1.9-fold) and E2F1 (+1.5-fold) in
Toxoplasma-infected HFFs relative to uninfected HFFs at 24h
post-infection. It is, therefore, probable that the Toxoplasma-
dependent increase in the levels of pri-miR-17,92 and pri-miR-
106b,25 are at least in part due to such changes in host
transcription factors.
Whether the increases in miR-17,92-derived miRNAs are
mediated by c-Myc, E2F or another pathway, the identity of the
parasite factor(s) that drive these changes are unknown. These
changes could involve one or more of the recently reported
effectors that the parasite injects into the host cell during infection.
These effectors include protein phosphatases [41] and protein
kinases [4,5], one of which has been shown to influence Toxoplasma
virulence by dramatically altering host transcription through
interacting with STAT3 and STAT6 functions [5]. Whether this
or one of the other injected Toxoplasma effectors is responsible for
the alterations in host miR-17,92 and miR-106b,25 expression,
and what role these changes play on the host-pathogen interaction
in vivo are the focus of on-going work.
Materials and Methods
Parasite Strains and Cell Culture
Parasites were propagated in primary HFFs and Vero cells
using standard cell culture techniques as described previously [12].
Manipulations and host cell passage histories are expanded in the
Detailed Materials and Methods (Appendix S1).
RNA Isolation
RNA was extracted with TRIzol (Invitrogen), and fractionations
were performed with the miRvanaTM miRNA isolation kit
(Ambion) or the Oligotex kit (Qiagen) according to the manu-
facturer’s instructions. Expanded RNA methods are provided in
the Detailed Materials and Methods (Appendix S1).
MicroRNA Microarray Profiling
Spotted oligonucleotide mirVanaTM miRNA Probe Set version
2 (Ambion) miRNA microarrays were purchased from the
Stanford Functional Genomics Facility. Extracted miRNAs were
39 end labeled with pCp-Cyanine dyes (pCp-Cy3 for common
reference, which was a mixture of all hybridized samples and pCp-
Cy5 for each individual experimental sample). pCp-Cyanine dyes
were synthesized at the Stanford PAN facility. Arrays were
hybridized, washed and processed according to the manufacturer’s
instructions (Ambion). Expanded microarray methods are provid-
ed in the Detailed Materials and Methods (Appendix S1).
Northern Blotting
MiRNA and pri-miRNA northern blotting were performed
essentially as previously reported [37]. For pri-miRNA northern
blotting, 100 mg total RNA samples were fractionated with
Oligotex (Qiagen) according to the manufacturer’s instructions
prior to 1% agarose/formaldehyde separation and capillary
transfer. Expanded northern blot methods are provided in the
Detailed Materials and Methods (Appendix S1).
Primer-Extension Analysis
MiRNA primer extensions were performed in a manner similar
to a previous report [23]. Expanded primer extension methods
provided in the Detailed Materials and Methods (Appendix S1).
Supporting Information
Figure S1 miRNA microarray profiling data of Toxoplasma-
infected primary human foreskin fibroblasts. Columns are
individual microarrays hybridized with labeled, size-fractionated
RNA derived from mock infected HFFs or Toxoplasma-infected
HFFs at the indicated time-points. Heatmap scale is from 23 to
+3, and these values reflect the log2-transformed ratios of the
hybridization intensities of Cy5-labeled sample/Cy3-labeled
common reference for each array. Common reference RNA was
a pooled mixture of RNAs from all samples. Data was filtered in
SMD according to the default settings, and only spots that were
called ‘present’ on 80% of the arrays were included in the
heatmap. Log2-transformed ratios of the hybridization intensities
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of sample/common reference for each spot on each array were
hierarchically clustered (Euclidean) in MEviewer (MeV4.2; TIGR)
by arrays and to genes. Red boxes are miR-17 family members;
blue boxes are miR-18 family members. has = human, mmu =
mouse, rno = rat, ambi = proprietary Ambion probe sequences.
Found at: doi:10.1371/journal.pone.0008742.s001 (9.27 MB TIF)
Figure S2 Northern blot analysis demonstrates that Toxoplasma
infection results in increased levels of mature miR-17 family
members. RNA samples derived from uninfected HFFs (- lanes),
and from HFFs infected with Toxoplasma for 24h (+ lanes) were
resolved through a 10% acrylamide/8M urea gel, transferred to
nylon membrane, and hybridized to miR-21, miR-17 and U6
oligonucleotide probes (corresponding probes are indicated
underneath autoradiographs). The U6 snRNA hybridization is
shown as a loading control. Putative pre-miRNA bands and
mature miRNA bands are indicated with arrows. A co-
electrophoresed 10nt ladder is shown for nucleotide size
comparison.
Found at: doi:10.1371/journal.pone.0008742.s002 (0.42 MB TIF)
Figure S3 Probe sequences used in this study. All oligonucleo-
tides are listed from 59 to 39. In ‘notes’ column, target nucleotide
positions are provided for all primer-extension probes. The
forward and reverse primers used in PCR amplification of the
pri-miR-17,92, pri-miR-106a,363, pri-miR-106b,25, AldoA,
MCM7 and RPS29 probes are shown.
Found at: doi:10.1371/journal.pone.0008742.s003 (0.33 MB
DOC)
Appendix S1 Detailed Materials and Methods. This Supple-
mental Information file contains expanded Materials and Methods
from the manuscript
Found at: doi:10.1371/journal.pone.0008742.s004 (0.06 MB
DOC)
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